Advertisement

Reactions Weekly

, Volume 1770, Issue 1, pp 137–137 | Cite as

Dabigatran-etexilate

Bleeding, anaemia and thromboembolic events: 4 case reports
Case report
  • 15 Downloads

Reference

  1. Akagi Y, et al. Retrospective cohort study of the efficacy and safety of dabigatran: Real-life dabigatran use including very low-dose 75 mg twice daily administration. Journal of Pharmaceutical Health Care and Sciences 5: 2019. Available from: URL: http://doi.org/10.1186/s40780-019-0145-3 - Japan

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations